Tom Coogan - Invion Insider

IVX -- Australia Stock  

AUD 0.041  0.002  5.13%

We currently do not have informatin regarding Tom Coogan. This executive tanure with Invion Limited is not currenlty determined.
  Executive Since 2012      
61 3 9081 6005

Management Efficiency

The company has return on total asset (ROA) of (12.35) % which means that it has lost $12.35 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (73.51) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 1.26 M in total debt with debt to equity ratio (D/E) of 15.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Invion Limited has Current Ratio of 0.25 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Similar Executives

Entity Summary

Invion Limited, a clinical-stage drug development company, develops treatments for inflammatory diseases in Australia and the United States. It has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers. Invion operates under Drug Manufacturers - Specialty Generic classification in Australia and traded on Australian Securities Exchange. It employs 1 people.Invion Limited (IVX) is traded on Australian Securities Exchange in Australia. It is located in 722 High Street and employs 1 people.

Invion Limited Leadership Team

Warren Brown, Non-Executive Director
Thian Chew, Non-Executive Chairman of the Board
Melanie Farris, Company Secretary
Gregory Collier, CEO, Managing Director
James Heading, Non-Executive Director
Mitchell Glass, Executive Vice President - Research & Development, Chief Medical Officer
Tom Coogan, Consultant
James Campbell, Non-Executive Director

Stock Performance Indicators

Current Sentiment - IVX

Invion Limited Investor Sentiment
Most of Macroaxis users are currently bullish on Invion Limited. What is your judgment towards investing in Invion Limited? Are you bullish or bearish?
98% Bullish
2% Bearish

Build Optimal Portfolios

Align your risk with return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Cryptocurrency Correlation module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges.